An AI-powered computational model has finally solved why physical pressure stops tumors in their tracks—a discovery that could fundamentally reshape how cancer is treated. Researchers from the University of Galway in Ireland and KU Leuven in Belgium built the innovative system to crack a mystery that has puzzled cancer scientists for decades: cancer cells somehow ignore the body's normal growth controls, yet they cannot override something simple and mechanical.
The phenomenon has been observed in laboratories for years. Put enough physical pressure on a tumor, and its growth slows dramatically. But no one fully understood why. The answer, it turns out, lies in the basic mechanics of how cells multiply. Before a cell can divide, it must grow larger by manufacturing complex biological molecules—proteins, lipids, and other building blocks—which draw water into the cell through osmosis, inflating it like a tiny balloon. Once the cell reaches a critical size, it divides in two. This process works smoothly under normal circumstances. But when a tumor becomes physically confined by surrounding tissue pressing inward, the external mechanical load creates high hydrostatic pressure that fights directly against the osmotic swelling from inside. The result is elegant in its simplicity: cells can no longer reach the size needed to trigger division. Growth stalls.
Dr. Irish Senthilkumar, a postdoctoral researcher and lead on the study published in Proceedings of the National Academy of Sciences, explained the research's motivation. "Cancer cells are known to bypass many of the body's normal growth controls, but tumors still respond to mechanical pressure. Until now we haven't understood why this happens, so our aim was to investigate the underlying mechanics at a cellular level."
The breakthrough wouldn't have been possible without artificial intelligence. The research team developed an AI-accelerated computational model capable of running complex calculations that would have been impossibly slow to complete otherwise. The model simulates how thousands of individual cells collectively grow and reorganize under mechanical stress—essentially showing what happens when cells have no room to expand. Scientists then validated these predictions against real laboratory experiments using breast cancer spheroids, small three-dimensional clusters of cancer cells grown in culture that closely mimic how tumors behave inside the body. The predictions matched the experimental results, confirming the team had identified the genuine mechanism.
The implications stretch far beyond explaining an interesting biological process. Dr. Eóin McEvoy, senior researcher at CÚRAM and Associate Professor of Biomedical Engineering at the University of Galway, noted that "as we understand more about how cell compression and compaction affect things like drug penetration and efficacy, the work has important implications for improving drug responses and designing new mechanotherapy treatment regimens."
Many cancer drugs work by targeting cell division. If a tumor's mechanical environment is already suppressing growth, understanding that interaction could reveal why some drugs work better in certain tumor types or locations, and why others fail. This discovery opens an entirely new role for treatments known as mechanotherapies in the fight against cancer—harnessing the pressure of physical force as a therapeutic tool rather than viewing mechanical constraints as merely passive features of tumor architecture. By recognizing the physical architecture of a tumor as an active participant in the disease, researchers have unlocked a door that could lead to more targeted, effective cancer treatments.